The Indian Pharmaceutical Market (IPM) is the largest business unit for Unison Pharmaceuticals.

India business is a branded generic business for Unison. After leaving a strong foot print in Gujarat State, Unison has established presence in Pan India market with product range in Cardiology and Diabetology segment. Unison's portfolio is focused towards pharmaceutical products used in chronic (including sub-chronic) therapeutic areas. With more than 500 sales personnel team and 200+ sku Unison ranked amongst top 50 companies (Unit wise sales) IQVIA MAT April 25.

Unison's domestic business has always been driven by technology-based innovation having launched multiple value-added products. With state-of-the-art manufacturing facilities meeting global standards, Unison ensures compliance with international regulations even for domestic products. Unison is known for providing high quality product at very affordable price across the product range.